Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers
Clinical trial NCT07184502 · RECRUITING
Trial details
- NCT number
- NCT07184502
- Sponsor
- Beijing QL Biopharmaceutical Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-16
- Primary completion
- 2026-12-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.